| Date | Title | Description | Source |
| 30.06.2021 | ViaCyte Raises $115 Million Series D | ViaCyte, a clinical stage biotech company, has raised $115 million in Series D financing, to bring f... | sdbj.com/n... |
| 19.06.2021 | ViaCyte Raises $45M in Funding | ViaCyte, a San Diego CA-based regenerative medicine company, raised $45M in Series D funding.
The r... | finsmes.co... |
| 09.06.2021 | ViaCyte Raised $45M to Be Used for Stem Cell Therapy Treatme... | - | connect.or... |
| 09.06.2021 | ViaCyte Raises $45M to Be Used for Stem Cell Therapy Treatme... | - | connect.or... |
| 09.06.2021 | ViaCyte Announces Closing of $45 Million Financing to Advanc... |
SAN DIEGO, June 9, 2021 /PRNewswire/ -- ViaCyte, Inc., a clinical-stage regenerative medicine comp... | prnewswire... |
| 09.06.2021 |
ViaCyte Scores $45M For Stem Cell Therapy
| San Diego-based ViaCyte, a company which is using stem cell technology to develop treatments for Typ... | socaltech.... |
| 08.06.2021 | ViaCyte Appoints Dr. Evert Kroon as Interim Chief Scientific... |
SAN DIEGO, June 8, 2021 /PRNewswire/ -- ViaCyte, Inc., a clinical-stage regenerative medicine comp... | prnewswire... |
| 03.02.2021 | ViaCyte Announces Initiation of Phase 2 Study of Encapsulate... |
SAN DIEGO, Feb. 3, 2021 /PRNewswire/ -- ViaCyte, Inc., a clinical-stage regenerative medicine comp... | prnewswire... |
| 29.01.2021 | Michael Yang leads list of moves at ViaCyte, succeeding ... | Michael Yang
→ The winds of change are freshening off the coast in San Diego for stem cell biotec... | endpts.com... |
| 27.01.2021 | ViaCyte Appoints Michael Yang President and CEO and Provides... |
SAN DIEGO, Jan. 27, 2021 /PRNewswire/ -- ViaCyte, Inc., a clinical-stage regenerative medicine com... | prnewswire... |
| 14.08.2020 | Sanofi vet Katherine Bowdish named CEO of PIC Therapeuti... | Katherine Bowdish
→ PIC Therapeutics hasn’t raised much money, yet. But the fledgling biotech... | endpts.com... |
| 16.06.2020 | The nanofibre ‘teabag’ that could replace diabetics’ insulin... | “It’s kind of like a teabag,” says Ann Kramer, chief executive of clinical biomaterials company Elec... | sifted.eu/... |
| 26.05.2020 | ViaCyte Announces $27 Million Financing to Advance Next Gene... | - | jnjinnovat... |
| 26.05.2020 | ViaCyte Closes Approximately $27M in Series D Financing | ViaCyte, Inc., a San Diego, CA-based regenerative medicine company, closed an approximately $27m in ... | finsmes.co... |
| 03.12.2018 | Term Sheet — Monday, December 3 | THE CRYSTAL BALL
Good morning, Term Sheet readers. Sending this from a plane, so the deals section ... | fortune.co... |
| 03.12.2018 | Daily funding roundup - December 3rd, 2018 | Floom raised $2.5M: Ascent360 raised $4.1M; Chewse raised $19M; Oura raised $20M
Floom: Floom is a ... | vator.tv/n... |
| 30.11.2018 |
ViaCyte Raises $80M In Series D Funding
| San Diego-based biotech startup ViaCyte, which is developing human cell therapy for treating diabete... | socaltech.... |
| 30.11.2018 | ViaCyte Secures $80M Series D Financing |
SAN DIEGO, CA, Privately-held clinical stage regenerative medicine company, today announced an $80... | vcnewsdail... |
| 30.11.2018 | ViaCyte Raises $80M in Series D Financing | ViaCyte, Inc., a San Diego, CA-based clinical stage regenerative medicine company, raised $80m in Se... | finsmes.co... |
| 29.11.2018 | ViaCyte Secures $80 Million Financing to Advance Functional ... | - | jnjinnovat... |
| 23.05.2017 | Term Sheet — Tuesday, May 23 | FALSE START
Good morning – today’s column didn’t come together in time. Back tomorrow!
• Can China... | fortune.co... |
| 22.05.2017 | ViaCyte Raises $10m in Financing | ViaCyte, Inc., a San Diego, CA-based regenerative medicine company, raised $10m in financing.
Backe... | finsmes.co... |
| 29.03.2017 | Gore joins ViaCyte’s quest for a functional type 1 diabetes ... | On Wednesday, the San Diego, California-based company announced a new partner; W. L. Gore & Asso... | medcitynew... |
| 25.08.2014 | ViaCyte Receives $20M |
SAN DIEGO, CA, ViaCyte, Inc., a privately held regenerative medicine company announced today that ... | vcnewsdail... |
| 22.08.2014 | Artificial pancreas-maker ViaCyte has new trials, funding, a... | This news followed right on the heels of ViaCyte’s announcement earlier this month that it secured $... | medcitynew... |
| 11.08.2014 |
ViaCyte Raises $5.4M
| San Diego-based ViaCyte, a biopharmaceuticals startup developing stem-cell based treatments for diab... | socaltech.... |
| 08.08.2014 | ViaCyte Completes $5.4M Series C-1 Financing | ViaCyte, Inc., a San Diego, California-based regenerative medicine company developing a stem cell-de... | finsmes.co... |
| 08.08.2014 | ViaCyte Raises $5.4M |
SAN DIEGO, CA, Privately held regenerative medicine company has raised $5.4M in Series C.
>>... | vcnewsdail... |
| 22.10.2013 | Research analysis finds “little tangible progress toward a c... | JDCA counts four practical cure approaches currently being developed: islet transplantation; drugs t... | medcitynew... |
| 11.07.2013 | ViaCyte ropes in $10.6M for artificial pancreas | ViaCyte said it closed a $10.6 million funding round for its artificial pancreas technology with the... | massdevice... |
| 10.07.2013 | ViaCyte Raises $10.6M Series C-1 |
SAN DIEGO, CA, leading regenerative medicine company focused on developing new approaches to treat... | vcnewsdail... |
| 10.07.2013 |
ViaCyte Snags $10.6M For Diabetes Treatments
| San Diego-based ViaCyte, a developer of stem-cell based treaments for diabetes, has raised $10.6M. A... | socaltech.... |
| 10.07.2013 | ViaCyte, Inc. Raises $10.6 Million in a Private Financing to... | - | jnjinnovat... |
| - | Vertex builds up pipeline of type 1 diabetes cell therapies ... | Vertex Pharmaceuticals is developing a cell therapy for type 1 diabetes that replaces the insulin-pr... | medcitynew... |
| - | Gore joins ViaCyte’s quest for a functional type 1 diabetes ... | A cure for type 1 diabetes has been “just around the corner” for decades now — or so patients have b... | medcitynew... |
| - | Research analysis finds “little tangible progress toward a c... | Not nearly enough of the funds donated to the four biggest diabetes non-profits end up in the hands ... | medcitynew... |
| - | Artificial pancreas-maker ViaCyte has new trials, funding, a... | San Diego’s ViaCyte is clearly up to plenty – the regenerative medicine company just announced it ha... | medcitynew... |
